Skip to content

Radiofrequency Catheter Ablation for Atrial Fibrillation and Supraventricular Tachycardia in Non-Fluoroscopic Catheterization Lab versus Traditional DSA Catheterization Lab: The FREE-DSA Trial

Radiofrequency Catheter Ablation for Atrial Fibrillation and Supraventricular Tachycardia in Non-Fluoroscopic Catheterization Lab versus Traditional DSA Catheterization Lab: The FREE-DSA Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108594
Enrollment
Unknown
Registered
2025-09-02
Start date
2025-09-16
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation and Supraventricular Tachycardia

Interventions

DSA-group:The radiofrequency catheter ablation surgery will be carried out in the traditional catheterization lab
FREE-group:The radiofrequency catheter ablation surgery will be carried out in the Non-Fluoroscopic Catheterization Lab

Sponsors

The first affiliated hospital of anhui medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia who are scheduled for radiofrequency ablation and meet the procedure indications; 2.Patients aged 18–80 years; 3.Patients who can provide written informed consent and comply with perioperative and follow-up requirements; 4.Patients with clear electrocardiographic diagnostic evidence.

Exclusion criteria

Exclusion criteria: 1.Patients with acute heart failure; 2.Patients with coagulation dysfunction; 3.Patients with left atrial thrombus; 4.Patients with severe liver or renal dysfunction; 5.Patients who have previously undergone cardiac surgery; 6.Patients who have previously undergone catheter ablation for atrial fibrillation or supraventricular tachycardia; 7.Patients with complex congenital heart disease; 8.Pregnant female patients; 9.Patients with cardiovascular structural abnormalities that may affect catheter placement, such as femoral vein malformations; 10.Patients with implanted devices that may interfere with catheter manipulation, such as atrial septal defect occluders, pacemakers, or pacemaker leads; 11.Patients requiring X-ray fluoroscopy during the procedure, such as vein of marshall ethanol ablation or left atrial appendage closure; 12.Patients currently participating in other interventional studies; 13.Patients deemed unsuitable for this study by the investigator;

Design outcomes

Primary

MeasureTime frame
The incidence of procedure-related complications;Immediate procedure success rate;

Secondary

MeasureTime frame
procedure time;Recurrence rate;X-ray fluoroscopy parameters;Hospitalization costs;

Countries

China

Contacts

Public ContactRonghui Yu

The first affiliated hospital of anhui medical university

ronghuiyu@vip.sina.com+86 551 62923102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026